Dataset Information


Loss of NAMPT in aging retinal pigment epithelium reduces NAD+ availability and promotes cellular senescence.

ABSTRACT: Retinal pigment epithelium (RPE) performs numerous functions critical to retinal health and visual function. RPE senescence is a hallmark of aging and degenerative retinal disease development. Here, we evaluated the temporal expression of key nicotinamide adenine dinucleotide (NAD+)-biosynthetic genes and associated levels of NAD+, a principal regulator of energy metabolism and cellular fate, in mouse RPE. NAD+ levels declined with age and correlated directly with decreased nicotinamide phosphoribosyltransferase (NAMPT) expression, increased expression of senescence markers (p16INK4a, p21Waf/Cip1, ApoJ, CTGF and ?-galactosidase) and significant reductions in SIRT1 expression and activity. We simulated in vitro the age-dependent decline in NAD+ and the related increase in RPE senescence in human (ARPE-19) and mouse primary RPE using the NAMPT inhibitor FK866 and demonstrated the positive impact of NAD+-enhancing therapies on RPE cell viability. This, we confirmed in vivo in the RPE of mice injected sub-retinally with FK866 in the presence or absence of nicotinamide mononucleotide. Our data confirm the importance of NAD+ to RPE cell biology normally and in aging and demonstrate the potential utility of therapies targeting NAMPT and NAD+ biosynthesis to prevent or alleviate consequences of RPE senescence in aging and/or degenerative retinal diseases in which RPE dysfunction is a crucial element.

PROVIDER: S-EPMC6046249 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6594813 | BioStudies
| S-EPMC5627432 | BioStudies
| S-EPMC7024650 | BioStudies
| S-EPMC3469563 | BioStudies
| S-EPMC6361564 | BioStudies
| E-GEOD-49784 | BioStudies
| S-EPMC5471593 | BioStudies
2016-01-01 | S-EPMC4823084 | BioStudies
| S-EPMC5844108 | BioStudies
| S-EPMC3482862 | BioStudies